The bispecific antibody therapeutics market - Roots Analysis | #roots Analysis # Research # Pharma # Biotech # Analysis # Market Research # Industry Reports # Business Report

The bispecific antibody therapeutics market - Roots Analysis

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

The contract fill / finish services market for - Roots Analysis | #roots Analysis # Research # Pharma # Biotech # Analysis # Market Research # Industry Reports # Business Report

The contract fill / finish services market for - Roots Analysis

A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

The opportunity for AR / VR based digital marketing service - Roots Analysis | #roots Analysis # Research # Pharma # Biotech # Analysis # Market Research # Industry Reports # Business Report

The opportunity for AR / VR based digital marketing service - Roots Analysis

Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies

Nuclear medicine and Radiopharmaceuticals Manufacturing | #roots Analysis # Research # Pharma # Biotech # Analysis # Market Research # Industry Reports # Business Report

Nuclear medicine and Radiopharmaceuticals Manufacturing

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market aut

Ophthalmic APIs and drug FDFs, claims Roots Analysis | #roots Analysis # Research # Pharma # Biotech # Analysis # Market Research # Industry Reports # Business Report

Ophthalmic APIs and drug FDFs, claims Roots Analysis

Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource